Navigation Links
Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
Date:9/28/2011

GREENWOOD VILLAGE, Colo., Sept. 28, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it has received notification of allowance of its two patent applications on Zertane™ combinations with erectile dysfunction (ED) drugs in Canada.  This allowance includes claims directed to the use of Zertane™ with a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors commonly used for the treatment of ED to address concurrent premature ejaculation (PE) and ED. The allowed claims also include composition of matter claims, such as claims directed to a pharmaceutical composition or a kit containing Zertane™ and a PDE5 inhibitor. Similar patent applications are being prosecuted worldwide.

It has been reported that ED and PE can co-exist in up to 30% of patients. There may be patients with ED who are effectively treated with phosphodiesterase type 5 inhibitors but who may have PE.  The patented combination of PE and ED drugs addresses this substantial group of patients.

"This first allowance of these two patents in Canada is an important milestone in Ampio's strategy to continue the development of its sexual dysfunction portfolio by first obtaining strong intellectual property protection," said Don Wingerter Ampio's CEO. "We are very excited by this development as we anticipate it will help increase our growing out-licensing activity for this product line," continued Don Wingerter.

About Zertane

The active ingredient in Zertane™ is a drug that was approved for marketing as a noncontrolled analgesic in 1995. In two Phase III clinical trials, Zertane™ has proven to be an effective oral medication to treat PE in men. Premature ejaculation
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation.
2. Champions Oncology Reports Fiscal 2012 First Quarter Financial Results
3. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
4. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
5. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
6. Ampio Pharmaceuticals Set to Join Russell 3000 Index
7. Ampio Pharmaceuticals, Inc. Appoints New Independent Director
8. Ampio Pharmaceuticals, Inc. to Begin Trading on the NASDAQ Capital Market
9. Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
10. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
11. Champions Biotechnology Exercises Option to License Proprietary Compound Based on Successful Tumorgraft™ Test Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015 ... Global Azithromycin Industry and 2015 Deep Research ... added to Pharmaceutical category in its database.  ... introduces Azithromycin basic information, including definition, classification, ... analysis, and news analysis, etc. Azithromycin Key ...
(Date:4/1/2015)...  Egalet Corporation (Nasdaq: EGLT ) ("Egalet"), ... developing, manufacturing and marketing innovative pain treatments, today ... million aggregate principal amount of its convertible senior ... placement to qualified institutional buyers pursuant to Rule ... amended (the "Act"). Egalet also granted the initial ...
(Date:4/1/2015)... SAN CLEMENTE, Calif. , April 1, 2015 /PRNewswire/ ... residents in the United States ... out amongst their resident colleagues. In its inaugural year, ... and 50 of the top nominations were narrowed to ... voting process that saw over 10,000 votes from colleagues ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4
... , , , , ... i c , Inc. (Nasdaq: ... medical imaging systems and surgical products dedicated to serving the healthcare needs ... study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic ...
... VIENNA, Va., Aug. 18 CEL-SCI Corporation (NYSE Amex: ... of its work towards creating a novel treatment and vaccination against ... in which the virus has acquired greater morbidity and mortality. ... are highly conserved and essential for the virus, survival. This ...
Cached Medicine Technology:Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 2Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 3Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth 4CEL-SCI Expands H1N1 Flu Virus Work 2CEL-SCI Expands H1N1 Flu Virus Work 3
(Date:4/1/2015)... New York, NY (PRWEB) April 01, 2015 ... currently reports there are “more than 123,000 patients who ... may not be aware of this surprising statistic. ... to Donate Life” PSA, Erik Compton, a PGA TOUR ... organ donation and encourages Americans to become organ donors. ...
(Date:4/1/2015)... 01, 2015 Nike Tennis Camps will ... and girls ages 10-17, providing campers with the opportunity ... will experience all 4 Grand Slam surfaces on 22 ... of Great Britain’s Davis Cup team and national governing ... Richmond Park, the National Tennis Centre is the perfect ...
(Date:4/1/2015)... 2015 ScooterDirect.com is a one stop ... improve their customers’ lifestyle using electric mobility scooters, power ... needs of the people, they provide mobility scooters at ... independent and enjoy their freedom. Scooterdirect.com is offering Pride ... prices. , One of the team members ...
(Date:4/1/2015)... With so much wet weather over the past ... their time indoors. When all this time is spent inside, ... latest article from Clean Crawls offers excellent advice to ... , One of the ways to improve the air ... The article states that, “Toluene, Xylene, and Benzene are all ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Eighty seven ... athletics grants from California Casualty . Many of ... reduced-cost lunches and subsequently have fewer and fewer dollars ... after California Casualty Chairman Emeritus Thomas R. Brown, who ... to the classroom. Since its inception in 2011, ...
Breaking Medicine News(10 mins):Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2Health News:3 Simple Ways to Improve Home Air Quality Listed by Clean Crawls in Latest Article 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5
... The decision by the Centers for Medicare ... also known as "virtual" colonoscopy, a radiographic examination of ... the test,s potential as an appropriate option for the ... the primary issues identified by CMS is that patients ...
... SHREVEPORT, La. and WOODRUFF, Wis., May 13 ... defibrillator (AED) Programs, and Allied 100, LLC (dba ... a strategic partnership to help customers deliver complete ... terms of the arrangement were not disclosed."En-Pro understands ...
... aren,t married, CDC reports , , , WEDNESDAY, May 13 ... has risen sharply in the United States and several other ... States, 40 percent of births are now to unwed mothers, ... not teenagers, according to a report, Changing Patterns of ...
... looked at obituary photographs published in one metropolitan newspaper suggests ... particularly for women. , The study found that the number ... age than when he or she died more than doubled ... twice as likely as men to have an obituary photo ...
... May 13 HealthSouth Corporation (NYSE: HLS ) ... Bank Health Care Conference in Boston on May 18-19, 2009.HealthSouth ... President of Operations Mark Tarr will be speaking on Tuesday, ... be webcast live and will be available at ...
... Boston Pharma announces the acquisition of NutraMax, ... dose and soft chew pharmaceuticals and supplements. The company ... Leading the First Boston Pharma organization is ... the industry,s foremost innovators in over-the-counter ("OTC") drugs and ...
Cached Medicine News:Health News:Decision by Medicare's CMS to Deny Coverage for 'Virtual' Colon Cancer Tests Underscores Lack of Evidence on Cancer Prevention 2Health News:AED Superstore and En-Pro Team Up to Provide Total Comprehensive, Tailored AED Programs 2Health News:AED Superstore and En-Pro Team Up to Provide Total Comprehensive, Tailored AED Programs 3Health News:More Single Women Are Having Babies 2Health News:More Single Women Are Having Babies 3Health News:More Single Women Are Having Babies 4Health News:Obituary photos suggest growing bias against aging faces 2Health News:Obituary photos suggest growing bias against aging faces 3Health News:First Boston Pharma, LLC Acquires NutraMax Products, Inc. 2
... the ALM X'Ten is a premier, major ... applications. , ,Its unique cross-shaped design and ... standards needed for your surgical environment. The ... surgical field., ,A 31" column of homogenous ...
The very bright medical maginifier lamp for examination and labratory....
... 360Fascia Closure Deviceprotects surgeons, nurses, and ... the threat of disease from deadly ... the same time enabling Gold Standard ... easily. The SuturTek 360Fascia Closure Devicealso ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
Medicine Products: